Repligen Stock Shares Owned By Institutions
RGEN Stock | USD 164.20 1.94 1.17% |
Repligen fundamentals help investors to digest information that contributes to Repligen's financial success or failures. It also enables traders to predict the movement of Repligen Stock. The fundamental analysis module provides a way to measure Repligen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repligen stock.
Repligen |
Repligen Company Shares Owned By Institutions Analysis
Repligen's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Repligen Shares Owned By Institutions | 93.41 % |
Most of Repligen's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 93% of Repligen are shares owned by institutions. This is 109.26% higher than that of the Life Sciences Tools & Services sector and 36.57% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 138.24% lower than that of the firm.
Repligen Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.Repligen is currently under evaluation in shares owned by institutions category among related companies.
Repligen Fundamentals
Return On Equity | 0.0214 | ||||
Return On Asset | 0.0131 | ||||
Profit Margin | 0.07 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 9.23 B | ||||
Shares Outstanding | 55.84 M | ||||
Shares Owned By Insiders | 6.59 % | ||||
Shares Owned By Institutions | 93.41 % | ||||
Number Of Shares Shorted | 4.59 M | ||||
Price To Earning | 154.58 X | ||||
Price To Book | 4.86 X | ||||
Price To Sales | 14.99 X | ||||
Revenue | 638.76 M | ||||
Gross Profit | 455.71 M | ||||
EBITDA | 131.39 M | ||||
Net Income | 41.58 M | ||||
Cash And Equivalents | 596.51 M | ||||
Cash Per Share | 10.75 X | ||||
Total Debt | 711.8 M | ||||
Debt To Equity | 0.23 % | ||||
Current Ratio | 2.30 X | ||||
Book Value Per Share | 35.35 X | ||||
Cash Flow From Operations | 113.92 M | ||||
Short Ratio | 10.84 X | ||||
Earnings Per Share | 0.75 X | ||||
Price To Earnings To Growth | 2.59 X | ||||
Target Price | 204.62 | ||||
Number Of Employees | 1.78 K | ||||
Beta | 1.01 | ||||
Market Capitalization | 9.28 B | ||||
Total Asset | 2.82 B | ||||
Retained Earnings | 438.85 M | ||||
Working Capital | 952.88 M | ||||
Current Asset | 103.25 M | ||||
Current Liabilities | 18.78 M | ||||
Net Asset | 2.82 B |
About Repligen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:Check out Repligen Piotroski F Score and Repligen Altman Z Score analysis. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.